National
Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode – The Lancet
Covaxin is India’s first indigenous vaccine against severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2), developed through a collaboration between Bharat…
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy Terms and Conditions
